NDC 55466-149-22 - Oseltamivir Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55466-149
- Requested NDC
- 55466-149-22
- Package NDCs from labels
- 55466-149-22
- Manufacturer
- Neolpharma, Inc.
- Effective date
- 2024-05-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oseltamivir Phosphate - Neolpharma, Inc. | Neolpharma, Inc. | 2024-05-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55466-149-22 | Oseltamivir Phosphate | 10 in 1 BOTTLE | CAPSULE | 10 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OSELTAMIVIR | OSELTAMIVIR | Alembic Pharmaceuticals Inc. | 82685c2f-791b-440f-a1c2-5a032da7adca | 2025-07-30 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Steritalc 2g | TALC | Novatech SA | c94e51d9-beef-4b06-e053-2a95a90a754a | 2025-06-25 | Warnings, Adverse reactions | 7SEV7J4R1U |
| oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Macleods Pharmaceuticals Limited | e9307620-36bd-46c2-a8b2-027d3fba87ba | 2025-06-18 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| SENSITIVE POCKET SUN | SENSITIVE POCKET SUN | Shantou Oushiya Biotechnology Co., Ltd | 36ac412f-e31f-6906-e063-6394a90a4a3d | 2025-06-14 | Warnings | 7SEV7J4R1U |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Teva Pharmaceuticals USA, Inc. | 3ea5bf8f-c3fa-4d44-bc3d-b1912374ee4b | 2025-05-01 | Warnings, Adverse reactions | 4A3O49NGEZ |
| oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Slate Run Pharmaceuticals, LLC | 613c8c4d-e647-4a4b-ac9b-c39aaa781ace | 2025-04-17 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Asclemed USA, Inc. | d9902b17-389b-45d4-b02f-67e35b0a5f3e | 2025-02-27 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Preferred Pharmaceuticals Inc. | 40312c99-5374-41fa-a687-c70d97445e24 | 2025-02-21 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| oseltamavir phosphate | OSELTAMAVIR PHOSPHATE | NuCare Pharmaceuticals,Inc. | 80511c6f-88b9-62d3-e053-2991aa0ab936 | 2025-02-06 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR ACID | Zydus Lifesciences Limited | 7c0923ad-80b0-4134-b44a-754ea599f356 | 2024-12-09 | 4A3O49NGEZ | |
| oseltamavir phosphate | OSELTAMAVIR PHOSPHATE | NuCare Pharmaceuticals, Inc. | 28ddaeb7-5903-4b59-e063-6294a90a2bcd | 2024-12-09 | Warnings, Adverse reactions | 728113 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | Zydus Lifesciences Limited | 58118069-cb24-4fa3-92d7-cabdc1b027f2 | 2024-12-03 | 728113 312122 728109 4A3O49NGEZ | |
| Oseltamivir phosphate | OSELTAMIVIR PHOSPHATE | Proficient Rx LP | 37eb95bb-3142-4355-8057-4e7c78443641 | 2024-12-01 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| Oseltamivir Phosphate for Oral Suspension | OSELTAMIVIR PHOSPHATE | NuCare Pharmaceuticals,Inc. | 27745acb-69a3-a1af-e063-6394a90ab10f | 2024-11-21 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | A-S Medication Solutions | 40390bf9-f2c4-4608-b5c4-315457b92821 | 2024-10-21 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | A-S Medication Solutions | 7c885cfb-46a0-4e18-ab96-03031b70b9d4 | 2024-10-21 | Warnings, Adverse reactions | 312122 4A3O49NGEZ |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EPIC PHARMA, LLC | 141c4005-89de-447e-961f-3780f62eded4 | 2024-09-17 | Warnings, Adverse reactions | 728113 312122 728109 4A3O49NGEZ |
| Oseltamivir Phosphate | OSELTAMIVIR PHOSPHATE | Lannett Company, Inc. | 005b2784-e410-a50c-e063-6394a90a881c | 2024-05-15 | Warnings, Adverse reactions | 4A3O49NGEZ |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| Oseltamivir Phosphate for Oral Suspension | OSELTAMIVIR PHOSPHATE | EPIC PHARMA, LLC | 1b17fffc-5774-4b9b-8440-3a5295a34f89 | 2023-12-27 | Warnings, Adverse reactions | 4A3O49NGEZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.